Trials / Sponsors / Angde Biotech Pharmaceutical Co., Ltd.
Angde Biotech Pharmaceutical Co., Ltd.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . Renal Anemia | Phase 2 | 2022-04-13 |
| Completed | A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE） Acute Ischemic Stroke | Phase 3 | 2022-03-21 |
| Unknown | Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA) Acute Pulmonary Embolism | Phase 2 | 2019-10-01 |
| Unknown | A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemi Acute Ischemic Stroke | Phase 2 | 2019-07-20 |
| Unknown | A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-in Chemotherapy-induced Thrombocytopenia | — | 2017-02-28 |